Xarelto 20 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FE4V9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $100,653
Award facts
- Contract value 100% obligated
- $100,653.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Xarelto 20 mg tablets (90-count) under a firm fixed-price contract with a ceiling value of $100,653.11 and ultimate completion date of September 8, 2025. This non-set-aside award represents a competitive delivery order executed by the prime contractor, whose corporate office is located in Conshohocken, Pennsylvania. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies a comprehensive range of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical supply needs through open competition, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Xarelto, an anticoagulant medication, reflects the company's ongoing role as a key supplier within the DLA's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DB25FE4V9?
SPE2DB25FE4V9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FE4V9 worth?
The government has obligated $100,653 on SPE2DB25FE4V9.
Is contract SPE2DB25FE4V9 an order under another contract?
Yes. SPE2DB25FE4V9 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FE4V9 competed?
The extent of competition for SPE2DB25FE4V9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award